Background: Kabuki syndrome (KS) is a rare multiple congenital anomalies/mental retardation syndrome characterized by a peculiar facial appearance. Recently, Maas et al. reported that exon 5 of the C20orf133 gene at 20p12.1 was disrupted by a 250-kb de novo microdeletion in a patient with KS and screened for mutations in C20orf133 and FLRT3 (a nested gene within intron 3 of C20orf133) in 19 additional patients with KS, but they failed to detect such mutations or deletions in any of the other patients.
Objective: To examine contribution of the two genes to KS, we performed mutation analysis, deletion assay and copy number analysis among Japanese patients with KS. Ethics approval for this study was obtained from the Committee for the Ethical Issues on Human Genome and Gene Analysis in Nagasaki University. The subjects studied consisted of 43 patients (20 girls and 23 boys) with KS from Japan for mutation analysis and a deletion assay, and of 18 patients (9 girls and 9 boys) with KS for copy number analysis. Genomic DNA was isolated by the standard method. Genomic sequences were retrieved from the UCSC genome browser. GenBank accession numbers of NCBI of C20orf133 and FLRT3 are NM_080676 and NM_198391, respectively.
C20orf133 and FLRT3 were directly sequenced. Polymerase chain reaction (PCR) primers used for the two genes were those described by Maas et al.. [1] , but some primers did not work in our laboratory, we newly designed the primes. Direct sequencing of C20orf133 and FLRT3 did not show any pathogenic nucleotide changes in the 43 patients. Observed five nucleotide changes in the patients were all found in normal Japanese individuals as well. ~750-kb at cytoband 4p16, known to be copy number variation. [6] . Therefore, we must be careful to check copy number changes for an MCA/MR syndrome.
To search particular microdeletion/duplication at cytoband 20p12.1, we performed copy number analysis among 18 patients with KS by DNA oligomicroarray hybridization using the GeneChip® Human Mapping 250K Nsp Array (Affymetrix, Santa Clara, CA, USA). Data at the target region were analyzed using GTYPE (GeneChip Genotyping Analysis Software), CNAT (GeneChip Chromosome Copy Number Analysis Tool) and Partek Genomic Suite v6.3 (Partek Inc., St. Louis, MO, USA). Two copy number changes were found among 18 patients. Neither of them was registered in the DGV, but they were less likely pathogenic because both of them were within intronic sequences. That is, a ~100-kb deletion within intron 5 of C20orf133 was detected in one patient (patient 3 in figure 1 In summary, we performed a mutation analysis for C20orf133 and FLRT3, a deletion assay for exon 5 of C20orf133 in 43 patients with KS and a copy number analysis by DNA oligomicroarray among the 18 patients with KS in Japan. These studies did not reveal pathogenic alterations in the patients. Thereby, our findings unfortunately could not support the working hypothesis that the C20orf133 and/or FLRT3 were the causative gene in most Japanese KS patients.
